[1]
N. Sukkasem, W. Chatuphonprasert, and K. Jarukamjorn, “Hesperidin and Myricetin Attenuated Non-Alcoholic Fatty Liver Disease (NAFLD) in HepG2 Cells: doi.org/10.26538/tjnpr/v4i10.14”,
TJNPR, vol. 4, no. 10, pp. 739–747, Oct. 2020, Accessed: Apr. 12, 2025. [Online]. Available:
https://tjnpr.org/index.php/home/article/view/1053